Patrick Cahan

Patrick Cahan

Auto-generated profile, based on publicly available information

Patrick Cahan

Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2010 in Nature
Verified
Journal Article
Open access
PDF file
KKK. Kim
K. Kim
ADA. Doi
A. Doi
BWBo Wen
Bo Wen
KNK. Ng
K. Ng
RZR. Zhao
R. Zhao
GDG. Q. Daley
G. Q. Daley
Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an ‘epigenetic memory’ of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer is more effective at establishing the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.

1 June 2014 in Cell
Verified
Journal Article
Closed access
DYDean Yimlamai
Dean Yimlamai
CCConstantina Christodoulou
Constantina Christodoulou
GGGiorgio G. Galli
Giorgio G. Galli
KYKilangsungla Yanger
Kilangsungla Yanger
BPBrian Pepe-Mooney
Brian Pepe-Mooney
FCFernando D. Camargo
Fernando D. Camargo

4 March 2012 in Nature
Verified
Journal Article
Open access
PDF file
TOTamer T. Onder
Tamer T. Onder
NKNergis Kara
Nergis Kara
ACAnne Cherry
Anne Cherry
ASAmit U. Sinha
Amit U. Sinha
NZNan Zhu
Nan Zhu
GDGeorge Q. Daley
George Q. Daley
Inhibition of DOT1L, the H3K79 histone methyltransferase, increases cell reprogramming and substituted for KLF4 and c-Myc, showing that chromatin-modifying enzymes act not only as facilitators but also as barriers to reprogramming. A study of the role of chromatin-modifying enzymes in the reprogramming of human fibroblasts to induced pluripotent stem (iPS) cells suggests that such enzymes can act as facilitators — but also as barriers — to epigenetic remodelling. By knocking down 22 selected genes involved in DNA and histone methylation pathways, George Daley and colleagues identified both positive and negative regulators of iPS-cell generation. In particular, inhibition of DOT1L, the H3K79 histone methyltransferase, increased reprogramming and substituted for KLF4 and c-Myc, two of the factors needed in the reprogramming cocktail. The effect of DOT1L inhibition seems to be associated with increase in the reprogramming factors NANOG and LIN28. This work demonstrates that specific chromatin modifiers can be modulated to generate iPS cells more efficiently and with fewer exogenously introduced transcription factors. Generation of induced pluripotent stem cells (iPSCs) by somatic cell reprogramming involves global epigenetic remodelling1. Whereas several proteins are known to regulate chromatin marks associated with the distinct epigenetic states of cells before and after reprogramming2,3, the role of specific chromatin-modifying enzymes in reprogramming remains to be determined. To address how chromatin-modifying proteins influence reprogramming, we used short hairpin RNAs (shRNAs) to target genes in DNA and histone methylation pathways, and identified positive and negative modulators of iPSC generation. Whereas inhibition of the core components of the polycomb repressive complex 1 and 2, including the histone 3 lysine 27 methyltransferase EZH2, reduced reprogramming efficiency, suppression of SUV39H1, YY1 and DOT1L enhanced reprogramming. Specifically, inhibition of the H3K79 histone methyltransferase DOT1L by shRNA or a small molecule accelerated reprogramming, significantly increased the yield of iPSC colonies, and substituted for KLF4 and c-Myc (also known as MYC). Inhibition of DOT1L early in the reprogramming process is associated with a marked increase in two alternative factors, NANOG and LIN28, which play essential functional roles in the enhancement of reprogramming. Genome-wide analysis of H3K79me2 distribution revealed that fibroblast-specific genes associated with the epithelial to mesenchymal transition lose H3K79me2 in the initial phases of reprogramming. DOT1L inhibition facilitates the loss of this mark from genes that are fated to be repressed in the pluripotent state. These findings implicate specific chromatin-modifying enzymes as barriers to or facilitators of reprogramming, and demonstrate how modulation of chromatin-modifying enzymes can be exploited to more efficiently generate iPSCs with fewer exogenous transcription factors.

27 November 2011 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
KKKitai Kim
Kitai Kim
RZRui Zhao
Rui Zhao
ADAkiko Doi
Akiko Doi
KNKitwa Ng
Kitwa Ng
JUJuli Unternaehrer
Juli Unternaehrer
GDGeorge Q Daley
George Q Daley
Mouse induced pluripotent stem (iPS) cells have been shown to retain an epigenetic 'memory' of their cell type of origin. Kim et al. study this question in human cells and document both incomplete erasure of methylation and aberrant de novo methylation during reprogramming. We compared bona fide human induced pluripotent stem cells (iPSCs) derived from umbilical cord blood (CB) cells and neonatal keratinocytes (K). As a consequence of both incomplete erasure of tissue-specific methylation and aberrant de novo methylation, CB-iPSCs and K-iPSCs were distinct in genome-wide DNA methylation profiles and differentiation potential. Extended passage of some iPSC clones in culture did not improve their epigenetic resemblance to embryonic stem cells, implying that some human iPSCs retain a residual 'epigenetic memory' of their tissue of origin.

1 August 2014 in Cell
Verified
Journal Article
Closed access
PCPatrick Cahan
Patrick Cahan
HLHu Li
Hu Li
SMSamantha A. Morris
Samantha A. Morris
EREdroaldo Lummertz da Rocha
Edroaldo Lummertz da Rocha
GDGeorge Q. Daley
George Q. Daley
JCJames J. Collins
James J. Collins

3 December 2014 in Nature
Verified
Journal Article
Open access
PDF file
RKRoshan M. Kumar
Roshan M. Kumar
PCPatrick Cahan
Patrick Cahan
ASAlex K. Shalek
Alex K. Shalek
RSRahul Satija
Rahul Satija
ADA. Jay DaleyKeyser
A. Jay DaleyKeyser
JCJames J. Collins
James J. Collins
Pluripotent stem cells (PSCs) are capable of dynamic interconversion between distinct substates; however, the regulatory circuits specifying these states and enabling transitions between them are not well understood. Here we set out to characterize transcriptional heterogeneity in mouse PSCs by single-cell expression profiling under different chemical and genetic perturbations. Signalling factors and developmental regulators show highly variable expression, with expression states for some variable genes heritable through multiple cell divisions. Expression variability and population heterogeneity can be influenced by perturbation of signalling pathways and chromatin regulators. Notably, either removal of mature microRNAs or pharmacological blockage of signalling pathways drives PSCs into a low-noise ground state characterized by a reconfigured pluripotency network, enhanced self-renewal and a distinct chromatin state, an effect mediated by opposing microRNA families acting on the Myc/Lin28/let-7 axis. These data provide insight into the nature of transcriptional heterogeneity in PSCs.